Anesiva
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Anesiva Information
Geographic Data
Address:
City: South San Francisco
State: California
Zip:
Country: United States
Financial Info
Stage:
post ipo debt
Raised Last:
$2M
Raised Total:$113M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.
Contact Phone:
Contact Email:
Anesiva went public on 2/12/2004 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/12/2004
Ticker Symbol:
CGTK
IPO Price:
$16/share
Amount Raised:
$96M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2002 | Series C | 6 | $50.4M |
Temasek Holdings HBM Healthcare Investments AG InterWest Partners Bear Stearns Health Innoventures L.P Alta Partners JPMorgan Partners Bear Stearns Health Innoventures L.P Temasek Holdings HBM Healthcare Investments AG InterWest Partners Bear Stearns Health Innoventures L.P Alta Partners JPMorgan Partners Bear Stearns Health Innoventures L.P |
1/2001 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
1/2009 | Post-IPO Equity | $3M | 6/2009 | Post-IPO Debt | $2M | 5/2001 | Series B | 3 | $13M |
JPMorgan Partners InterWest Partners Alta Partners |
12/2007 | Post-IPO Equity | 1 | $25M |
Alta Partners Alta Partners |
10/2003 | Series D | 3 | $20M |
Alta Partners InterWest Partners JPMorgan Partners Alta Partners InterWest Partners JPMorgan Partners |
1/2001 | Venture Round | 1 | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2005 | AlgorX |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
